100
Participants
Start Date
April 14, 2014
Primary Completion Date
January 31, 2017
Study Completion Date
May 29, 2023
PCD
"STUDY TREATMENT PHASE: All patients~* 4x 28 days cycles of PCD~\[Pomalidomide: 4mg/day oral route on 21 days per cycle\]~\[Cyclophosphamide: 300mg/day oral route on days 1, 8, 15, 22 per cycle\]~\[Dexamethasone: 40mg/day oral route on days 1, 2, 3, 4 and 15, 16, 17, 18 per cycle\]~CONSOLIDATION PHASE: depends on previous IFM/DFCI 2009's arm:~Arm A:~* Melphalan 200mg/m2 followed by Autologous Transplantation~* 2x 28 days cycles of PCD, three months post transplantation~Arm B:~* 5x 28 days cycles of PCD~\[Pomalidomide: 4mg/day oral route on 21 days per cycle\]~\[Cyclophosphamide: 300mg/day oral route on days 1, 8, 15, 22 per cycle\]~\[Dexamethasone: 40mg/day oral route on days 1, 8, 15, 22 per cycle\]~MAINTENANCE PHASE: All patients~\- Until progression/relapse or discontinuation for any other reason~\[Pomalidomide: 4mg/day oral route on 21 days per cycle\]~\[Dexamethasone: 20mg/day oral route on days 1, 8, 15, 22 per cycle\]"
Autologous transplantation (ASCT)
"Arm A:~•Melphalan 200mg/m2 followed by Autologous Transplantation"
Institut Paoli Calmette, Marseille
Institut d'Hématologie de Basse Normandie - IHBN, Caen
CHRU Dijon, Dijon
Centre Hospitalier Yves Le Foll, Saint-Brieuc
ICH - Hôpital A. Morvan, Brest
CHU Carémeau, Nîmes
Institut Universitaire du Cancer Toulouse-Oncopôle (IUCT-O), Toulouse
CHRU Hôpital Haut Lévêque, Pessac
CHRU Hopital Pontchaillou, Rennes
CHRU Hopital Bretonneau, Tours
Chru Grenoble, Grenoble
CHU de Nantes, Nantes
CHRU Hopitaux de Brabois, Vandœuvre-lès-Nancy
CHRU - Hôpital Claude Huriez, Lille
Centre Hospitalier Général, Dunkirk
Chu Estaing, Clermont-Ferrand
Centre Hospitalier de la côte Basque, Bayonne
Hopital Emile Muller, Mulhouse
Centre Hospitalier Lyon Sud, Pierre-Bénite
Clinique Victor Hugo, Le Mans
Centre Hospitalier Annecy Genevois, Pringy
CHRU Hopital Saint Antoine, Paris
Centre Henri Becquerel, Rouen
CHRU Hopital Sud, Amiens
Centre Hospitalier départemental de Vendée, La Roche-sur-Yon
CHU de Limoges, Limoges
Centre René Huguenin, Saint-Cloud
Hôpital Avicenne, Bobigny
CHU Henri Mondor, Créteil
Institut Curie, Paris
Collaborators (1)
Intergroupe Francophone du Myelome
NETWORK
Celgene Corporation
INDUSTRY
Institut Curie
OTHER